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1. Introduction
  Diabetes mellitus (DM) is the metabolic endocrine disease 
characterized by the disturbance of fat and glucose 
metabolism and rise of glucose level in the plasma, which 
will result in the injuries of multiple organs in the end stage. 
Diabetic nephropathy (DN) is one of common microvascular 
complications for the DM and it has become the leading 
cause for the end stage renal disease in recent years[1,2]. 
Presently, it is considered that the incidence of DN is 
influenced by many aspects, including the hemodynamic 
disorders, genetic factor and disorder of biochemical 
metabolism[3]. In recent years, theories of inflammation 
and immunity have attracted much attention. Researches 
indicate that the occurrence and development of DM are 
closely related to the platelet activation and endothelial cell 
loss. Toll-like receptors (TLRs) are the key transmembrane 
proteins to transfer the information of antigen recognition 
from outside to inside of the cell, as an important factor in 
the immune reaction[4]. TLR is the main part of mediated 
immune and inflammatory reaction, while TLR4 plays an 
important role both in the recognition of lipopolysaccharide 
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and signal transduction of mediated inflammatory reaction[5]. 
Researchers pay more attention to its role in the kidney 
diseases. This paper studies the mechanism of TLR4 in the 
DN, in order to find the new method to treat the DN.
2. Materials and methods
2.1. Experimental animals
   A total of 60 clean male SD rats (purchased from the 
provincial experimental animal center, number of quality 
certification: JZDW2011-0197) with the weight of 160-200 g 
were selected. All rats had sufficient water every day under 
20-24 曟 and 40%-70% humidity. The model of DN rat was 
established after 1 week of breeding.
 
2.2. Main reagents and materials
  TLR4 antibody, Trizol, DEPC and RT-PCR kit were 
purchased from Sigma-Aldrich and agarose, ethidium 
bromide, chloroform, isoamyl alcohol, ethanol absolute 
and isopropyl alcohol were provided by the laboratory. 
Instruments included the ultra-low temperature freezer 
(Midea Group), ultraviolet spectrophotometer (Shanghai 
Jing Hong Laboratory Instrument Co., Ltd.), iCycler PCR 
amplification instrument (Bio-Rad; USA) and DC2000 gel 
image analyzer (Bio-Rad; USA).
2.3. Modeling of DN rats and group division
  Rats were divided into the modeling group and control 
group after 1 week of breeding, including 30 rats in each 
group. Modeling of DN rats was as follows: (1) Firstly, 2.1 g 
citric acid was added to 100 mL distilled water as solution 
A and then 2.49 g trisodium citrate was added to 100 mL 
distilled water as solution B. Solution A was mixed with B 
by the ratio of 1:1.32 to get 0.1 mmol/L citric acid-trisodium 
citrate buffer solution. pH level of the buffer solution was 
adjusted to 4.5 by hydrochloric acid and sodium hydroxide; 
(2) A total of 600 mg streptozocin (STZ) was added to 60 mL 
citric acid-trisodium citrate buffer solution and rats were 
injected with STZ injection within 5min after the preparation; 
(3) All rats were fasted for one night, where the modeling 
rats received the intraperitoneal injection of STZ solution 
with the dosage of 65 mg/kg and the control ones received 
the injection of citric acid-trisodium citrate buffer solution 
with the dosage of 65 mg/kg; (4) Fasting blood glucose level 
of modeling rats after 1 week was detected. If it was higher 
than 16.7 mmol/L and the urine glucose was positive for 3 
d (+++), then the modeling succeeded, otherwise it failed 
and would be given up. Six rats were killed in each group 
respectively at 2 w, 4 w, 6 w, 8 w and 12 w after the success 
of modeling. All rats accepted the free feeding without 
the insulin during the experiment and under the standard 
laboratory environment.
2.4. Samples collection and treatment
  One day before killing, their urine was collected by 
metabolic cage for 24 h and storeed in the refrigerator under 
-80 曟 for 24 h protein in urine test. Rats accepted one-
night fasting before being killed for the weighing. Blood was 
collected from the caudal vein to measure the fasting blood 
glucose (blood glucose meter). After the ether inhalation 
anesthesia, the blood was collected from the abdominal 
aorta. After standing for 2 h, the blood was centrifuged at 
3 000 r/min for 10 min. Supernatant was taken and stored in 
the refrigerator under -20 曟 to detect the serum creatinine 
(by the automatic biochemical analyzer), urea nitrogen 
(by the automatic biochemical analyzer) and C-reactive 
protein (CRP) (by the scattering immunoturbidimetric assay). 
Kidneys were removed at both sides and the left one was 
weighted. Part of tissues was stored in the liquid nitrogen 
and detected in the laboratory together. The total RNA was 
extracted by Trizol method and then underwent the cDNA 
synthesis and polymerase chain reaction (PCR), with the 
upstream primer of TLR4, 5-GATTGCTCAGACATGGCAGT-3 
and downstream primer, 5-CCCACTCGAGGTAGGTGTTT-3. 
Agarose gel electrophoresis was performed for products of 
RCR. It was analyzed by DC2000 gel image analyzer and the 
fragment size of TLR4 was 137 bp. Part of them were fixed 
by the neutral formalin and wrapped by the paraffin. The 
pathological examination and immunohistochemical analysis 
were performed on kidney tissues.
  
2.5.  Pathological analysis of kidney tissues and detection of 
glomerular extracellular matrix
  PAS staining was taken after the section of paraffin to 
observe the pathological change of kidney and measure 
the cross-section of glomerulus. The mean was regarded 
as the cross-section area of glomerulus for each sample 
[mean glomerular area (MGA)] and the mean glomerular 
volume (MGV) was calculated by the calculation formula of 
MGV=1.25暳(MGA)3/2.
2.6. Detection of TLR4 expression
   The immunohistochemical staining was taken for detection 
of TLR4 expression in kidney tissues (rabbit anti-rat TLR4 
polyclonal antibody, sigma and Evision kit for the staining). 
mRNA expression of TLR4 in kidney tissues of rats was 
detected by reverse transcription-polymerase chain reaction 
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(RT-PCR).
2.7.  Statistical analysis
  It was analyzed by SPSS 16.0. Data was expressed as mean 
standard deviation. t test and LSD method were used for the 
group comparison and Pearson correlation for the multiple 
factor analysis. P<0.05 was considered as significant 
difference.
3. Results
3.1. Kidney weights and body weight 
  Modeling results showed that two groups had the symptoms 
of listlessness, fluff binding and decrease of self-cleaning 
activity, and significant polydipsia, polyphagia, polyuria 
and weight loss after the modeling. Compared to the control 
group, the kidney/body weight ratio in the modeling group 
was significantly higher after the modeling, with the 
statistical difference (P<0.05).
3.2. Biochemical indices 
  Rats in the modeling group had higher the blood glucose, 
24 h urine protein and blood urea nitrogen after the 
modeling, with the statistical difference in the increase of 
serum creatinine, kidney/body weight ratio, CRP and serum 
TNF-毩 after 4 w of modeling compared to the control group 
(P<0.05) (Table 1).
3.3. Extracellular matrix proliferation of DN rats at different 
time points
  There was no significant change in kidney tissues of the 
control group. But the volume of glomerulus increased 
at 4 w, the visible mesangial region widened at 12 w, 
extracellular matrix assembled and chromatin reconstitution 
of PAS increased in the modeling group. The cross-section 
area and mean volume of glomerulus in the modeling group 
at 4 w, 6 w, 8 w and 12 w were significantly higher than 
ones in the control group, with the statistically significant 
difference (P<0.05) (Table 2).
3.4. Protein expression of TLR4
 The expression of TLR4 at each time point in the control 
group was relatively low. Rats in the modeling group had the 
high expression of TLR4 in kidney’s glomerular basement 
membrane, proximal convoluted tubule and renal interstitial 
area since 2 w, with the significant difference compared to 
Table 1
Biochemical indices at different time points.
Group Blood glucose 
(mmol/L)
U r i n e  p r o t e i n 
(mg/24h)
Serum creatinine 
(毺mol/L)
B l o o d  u r e a 
nitrogen (mmol/L)
Kidney/body weight 
ratio (mg/g)
CRP 
(毺g/L)
TNF-毩
(毺g/L)
Control group   4.4暲0.3   1.2暲0.7   55.6暲8.9   5.5暲2.3 4.2暲0.6   4.3暲2.1 1.1暲0.3
Modeling group 2 w 22.3暲3.4* 10.1暲6.3*   58.3暲10.2   9.3暲2.2* 4.6暲0.8   4.3暲2.4 1.1暲0.2
4 w 23.2暲3.2* 11.8暲7.1*   63.6暲7.8   8.9暲3.1* 5.6暲1.0*   5.2暲3.5* 1.6暲0.3*
6 w 19.6暲4.1* 11.2暲6.9*   75.5暲11.3* 11.5暲4.7* 6.3暲1.2* 10.6暲6.3* 1.9暲0.4*
8 w 25.6暲2.8* 10.1暲7.6*   82.6暲11.5* 16.2暲4.8* 6.3暲0.8* 15.5暲4.1* 2.1暲0.5*
12 w 26.1暲2.0* 11.3暲7.7* 101.7暲15.8* 13.6暲4.0* 6.1暲1.3* 21.2暲6.4* 2.6暲0.4*
*: Compared to the control group, P<0.05.
Table 2
Extracellular matrix proliferation of DN rats at different time points.
Group Control group Modeling group 
at 2 w
Modeling group 
at 4 w
Modeling group 
at 6 w
Modeling group 
at 8 w
Modeling group 
at 12 w
Cross-section area of glomerulus (毺m
2
) 6 321.4暲326.2 6 464.3暲356.1 7 135.2暲413.7* 7 069.5暲408.3* 7 432.6暲511.6* 8 013.7暲623.5*
Mean volume of glomerulus (103毺m 
3
)    631.8暲47.6    672.6暲51.3    786.4暲58.6*    713.2暲60.1*    826.4暲65.3*    925.6暲46.7*
*: Compared to the control group, P<0.05.
Table 3
Protein expression of TLR4 (%).
Group 2 w 4 w 6 w 8 w 12 w
Modeling group 7.65暲1.74* 8.31暲2.06* 8.58暲2.42* 10.53暲3.71* 11.86暲4.12*
Control group 3.24暲0.68 3.26暲0.65 3.20暲0.64 3.22暲0.66 3.28暲0.64
*: Compared to the control group, P<0.05.
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the control group (P<0.05) (Table 3).
3.5. TLR4 mRNA expression in rat’s kidney
  The expression in rats of the modeling group was higher 
than the one of the control group since the 2nd week. As the 
time flied, its expression increased, with the statistically 
significant difference between two groups (P<0.05). TLR4 
expression at each time point in the control group was 
relatively low (Figure 1).
2 w    4 w     6 w      8 w       12 w      2 w       4 w        6 w       8 w      12 w 
A       A       A         A           A          B          B           B          B          B
Figure 1. TLR4 mRNA expression in rat’s kidney. 
A: Control group; B: Modeling group
3.6. Protein expression of TLR4 and multiple factors 
correlation analysis
  There was the certain correlation between the protein 
expression of TLR4 and the increased serum titer of 24-hour 
urine protein excretion, serum creatinine, CRP and TNF-毩 
(Table 4).
Table 4
Protein expression of TLR4 and multiple factors correlation analysis 
Indexes Protein expression of TLR4
Correlation coefficient r P value
24-hour urine protein excretion 0.899 0.039
Serum creatinine 0.941 0.016
CRP 0.858 0.021
TNF-毩 0.843 0.018
4. Discussion
  DM is a common metabolic endocrine disease characterized 
by the disturbance of glucose and fat metabolism and 
rise of glucose level in the plasma. Its pathologic and 
physiological characteristics are the absolute or relative 
insulin hyposecretion and increased activity of pancreatic 
glucagon which result in the metabolic disturbance. There 
are numerous patients with DM all around the world. 
According to statistics, the number of patients with DM 
was up to 239 million in 2010. Besides, with the change 
of lifestyle, the number of patients with DM tends to be 
increased. The DM can affect multiple systems of the whole 
body, along with many complications. Where, DN is the most 
important microvascular disease and it is also one of key 
factors to cause the end-stage rental failure. Presently, it is 
considered that the incidence of DN is influenced by many 
aspects, including the hemodynamic disorders, disorder 
of biochemical metabolism regarding the high glucose and 
genetic factor. Theories of inflammation and immunity 
have attracted much attention. Researches indicate that the 
occurrence and development of DM are closely related to the 
platelet activation and endothelial cell loss. TLRs are the 
only key transmembrane proteins in mammals to transfer 
the information of antigen recognition from outside to inside 
of the cell, as an important factor in the immune reaction. 
TLR is the main part of mediated immune and inflammatory 
reaction, while TLR4 plays an important role both in the 
recognition of lipopolysaccharide and signal transduction of 
mediated inflammatory reaction[6,7].
  Presently, there are limited researches on the relationship 
between TLR4 and DN. The correlation between them is 
generally rooted in researches on complications of DM. Dasu 
et al[8] found that there is increased expression of TLR4 in 
the peripheral blood of patients with type 1 and type 2 DM, 
which is related to the inflammatory reaction. Meanwhile, 
ShiH et al indicated that rats with TLR4 defect would become 
fat after the high-fat diet, but it could partially prevent 
the insulin resistance induced by the high-fat diet, which 
showed that the activation of TLR4 pathway was related to 
the insulin resistance[9]. The insulin resistance is the key 
mechanism for the occurrence of type 2 DM. The insulin 
treatment can reduce the blood glucose and the expression 
of TLR4 protein[10]. Furthermore, researches also indicated 
that the up-regulated expression of TLR4 could cause the 
occurrence of diabetic peripheral neuropathy, diabetic 
retinopathy and atherosclerosis[11-13]. There are limited 
researches on TLR4 in the inflammatory activation pathway 
and expression change of DN. Based upon the observation 
of TLR4 expression in the glomerulus of rats with DN, this 
paper discusses the role of TLR4 in the occurrence and 
development of DN.
  We adopt the intraperitoneal injection of STZ solution 
for the modeling of rats with DN and take the detection by 
methods of immunohistochemistry after the modeling. This 
research shows that the expression of TLR4 is mainly on the 
basement membrane and amniotic fluid and membrane of 
part vascular endothelial cell. It also shows that rats in the 
modeling group have the increased expression of TLR4 in 
glomerulus since 2 w and maintain the high level of blood 
glucose, 24-hour urine protein and blood urea nitrogen after 
the modeling. Then the level of serum creatinine, kidney/
body weight ratio, CRP and serum TNF-毩 increases and 
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the increase tendency becomes significant as the course of 
disease prolongs. The correlation analysis shows that there 
is the high positive correlation between TLR4 expression and 
serum TNF-毩 and CRP. Abundant researches also prove 
the critical role of TGF-毩1 and CRP in the development of 
DN-induced renal fibrosis.
  In this immunohistochemistry experiment, we found that 
the protein expression of TLR4 in renal tubule of rats with 
DN was significantly higher than the one in the control 
group and PCR results also showed that the expression of 
TLR4 in the kidney of rats in the modeling group was higher 
than the one in the control group since 2 w. The expression 
increases as the time flies with the statistical difference 
between two groups (P<0.05). It indicates that the expression 
of TLR4 in the renal tubular epithelium mediates the tubular 
substance leukocyte infiltration and tubular injury. The 
increased expression of TLR4 in the glomerulus can activate 
the immunocyte and renal parenchymal cell. It excretes 
abundant inflammatory mediator and cytokine and causes 
the continuous inflammatory reaction that promotes the 
tubular interstitial fibrosis and glomerular sclerosis.
  In conclusion, this research shows that there is the high 
positive correlation between the expression of TLR4 and the 
degree of inflammatory reaction, kidney injury and tissue 
fibrosis, which indicates that TLR4 in the occurrence and 
development of DN may cause the continuous inflammatory 
reaction and activate the immune reaction of kidney tissue. 
The interference in the expression of TLR4 in kidney tissues 
may delay the occurrence and development of DN.
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